P&G Outpaces J&J in Dividend Growth Amid Corporate Changes

Procter & Gamble's steady dividends have outpaced those of Johnson & Johnson due to the latter's planned corporate change. J&J is preparing a mid-2027 spinoff of its DePuy Synthes unit, which could disrupt its dividend streak despite strong revenue growth.

P&G's fiscal 2026 showed organic sales growth and over $15 billion returned to shareholders, supporting its dividend stability. Investors seeking reliable retirement income may prefer P&G for its consistent dividend strategy and absence of structural changes.